Pages that link to "Q30493038"

The following pages link to Comorbidity between epilepsy and depression: role of hippocampal interleukin-1beta (Q30493038):

Displaying 32 items.

• Biomarkers of epileptogenesis: psychiatric comorbidities (?) (Q27015612) (← links)
• Issues related to symptomatic and disease-modifying treatments affecting cognitive and neuropsychiatric comorbidities of epilepsy (Q27026690) (← links)
• Common Mechanisms Underlying Epileptogenesis and the Comorbidities of Epilepsy (Q30249189) (← links)
• Upregulation of STREX splice variant of the large conductance Ca2 -activated potassium (BK) channel in a rat model of mesial temporal lobe epilepsy (Q30497593) (← links)
• Interleukin-1β causes fluoxetine resistance in an animal model of epilepsy-associated depression (Q30513801) (← links)
• Rhythm and blues: animal models of epilepsy and depression comorbidity (Q33974889) (← links)
• Comorbidity between epilepsy and depression: experimental evidence for the involvement of serotonergic, glucocorticoid, and neuroinflammatory mechanisms (Q34015810) (← links)
• Depression and epilepsy: epidemiologic and neurobiologic perspectives that may explain their high comorbid occurrence. (Q34282867) (← links)
• Plasticity of Presynaptic and Postsynaptic Serotonin 1A Receptors in an Animal Model of Epilepsy-Associated Depression (Q34798592) (← links)
• Epileptogenesis after prolonged febrile seizures: Mechanisms, biomarkers and therapeutic opportunities (Q35028306) (← links)
• Inhibition of glutamine synthetase in the central nucleus of the amygdala induces anhedonic behavior and recurrent seizures in a rat model of mesial temporal lobe epilepsy (Q36328116) (← links)
• Effects of selective serotonin and norepinephrine reuptake inhibitors on depressive- and impulsive-like behaviors and on monoamine transmission in experimental temporal lobe epilepsy (Q36664940) (← links)
• Antidepressant therapy in epilepsy: can treating the comorbidities affect the underlying disorder? (Q36709214) (← links)
• Behavioral impairments in rats with chronic epilepsy suggest comorbidity between epilepsy and attention deficit/hyperactivity disorder (Q37624913) (← links)
• Activation of brain indoleamine 2,3-dioxygenase contributes to epilepsy-associated depressive-like behavior in rats with chronic temporal lobe epilepsy (Q37684964) (← links)
• Finding a better drug for epilepsy: antiinflammatory targets (Q38018121) (← links)
• Disentangling the relationship between epilepsy and its behavioral comorbidities - the need for prospective studies in new-onset epilepsies (Q38170903) (← links)
• Neurobehavioral comorbidities of epilepsy: Role of inflammation. (Q38694557) (← links)
• Pharmacokinetic/pharmacodynamic considerations for epilepsy - depression comorbidities. (Q38856602) (← links)
• Interleukin-1 β-targeted treatment strategies in inflammatory depression: toward personalized care. (Q38981762) (← links)
• Managing epilepsy-associated depression: Serotonin enhancers or serotonin producers? (Q39063138) (← links)
• The Wistar Audiogenic Rat (WAR) strain and its contributions to epileptology and related comorbidities: History and perspectives. (Q39307693) (← links)
• Neurobiology of depression as a comorbidity of epilepsy (Q42683520) (← links)
• Serotonin reuptake inhibitors are associated with reduced severity of ictal hypoxemia in medically refractory partial epilepsy (Q43057278) (← links)
• Galanin contributes to monoaminergic dysfunction and to dependent neurobehavioral comorbidities of epilepsy. (Q46510327) (← links)
• Epilepsy as a Network Disorder (1): What can we learn from other network disorders such as autistic spectrum disorder and mood disorders? (Q47580007) (← links)
• Can Neurochemical Changes of Mood Disorders Explain the Increase Risk of Epilepsy or its Worse Seizure Control? (Q47839769) (← links)
• Lamotrigine positively affects the development of psychiatric comorbidity in epileptic animals, while psychiatric comorbidity aggravates seizures (Q47877954) (← links)
• Evidence in support of using a neurochemistry approach to identify therapy for both epilepsy and associated depression (Q48048624) (← links)
• Targeting the Mouse Ventral Hippocampus in the Intrahippocampal Kainic Acid Model of Temporal Lobe Epilepsy (Q58795347) (← links)
• Affective, neurocognitive and psychosocial disorders associated with traumatic brain injury and post-traumatic epilepsy (Q90613286) (← links)
• Depressive, inflammatory, and metabolic factors associated with cognitive impairment in patients with epilepsy (Q90756629) (← links)